To evaluate computed tomographic (CT) colonography performance and program outcome measures in an older cohort (65-79 years) of an established large-scale colorectal cancer screening program.
Study Group
Our retrospective study, which complied with the Health Insurance Portability and Accountability Act, was approved by the institutional review board at the University of Wisconsin. The requirement for informed consent was waived. Between April 2004 and July 2008, 5176 adults were enrolled in the University of Wisconsin CT colonography screening program. The patients were individuals at average risk who were referred for colorectal cancer screening from Madison, Wis, and the surrounding region. Patients with a prior history of cancer, infl ammatory bowel disease, or polyposis syndrome and those who were under surveillance for prior adenomas were excluded. The 577 (11.1%) patients who were between 65 and 79 years old were included in our study cohort.
CT Colonography Reporting and Data System (C-RADS) conventions were prospectively applied to all CT examinations ( 9 ) . Patients with examinations with no polyps or only diminutive ( Յ 5-mm) polyps were deemed to have negative fi ndings (ie, C-RADS category C1) and were relegated to routine screening at a 5-year interval. Patients with at least one polyp 6 mm or greater in size were considered to have positive fi ndings and were given the option of therapeutic colonoscopy referral for polypectomy. Unless the patient had a contraindication, same day referral was attempted to allow removal of the polyp without the need for an additional bowel C omputed tomographic (CT) colonography has matured into an effective screening technique. It has accuracy equivalent to that of optical colonoscopy (OC) for the detection of advanced neoplasia ( 1, 2 ) . Advanced neoplasia is an optimal target for colorectal cancer screening and is defi ned as (a) a large ( Ն 10-mm) tubular adenoma, (b) an adenoma of any size with a substantial villous component or high-grade dysplasia (HGD), or (c) invasive cancer. CT colonography is now one of the preferred options in the American Cancer Society colorectal cancer screening guidelines ( 3 ) . The recent addition of CT colonography may have a major effect on future public health, as up to 40% of the eligible population does not undertake screening with the traditional options ( 4 ). Reported screening adherence is even worse for the older cohort of Medicare patients ( 5 ) . Evidence from several large CT colonography centers suggests that CT colonography may substantially increase overall screening numbers for a given population ( 6, 7 ) . Thus, CT colonography may be particularly helpful in the older screening population, representing a safer less invasive alternative to colonoscopy. However, there is limited age-specifi c data regarding utility in this cohort. Questions have arisen regarding whether factors such as performance, referral rate to colonoscopy, and the rate of incidental extracolonic fi ndings could vary from the reported values in the general population and, thus, have a substantial negative effect on CT colonographic screening in this group ( 8 ) . The purpose of our
Implication for Patient Care
CT colonography is an effective n means for screening the older population.
Advances in Knowledge
The prevalence of advanced neon plasia detected with CT colonography in this older cohort (65-79 years) was 7.6%.
Optical colonoscopy referral rate n after CT colonography was 15.3%.
Extracolonic work-up rate was n 7.8%, and important extracolonic diagnoses were found in 3.6% of older screened individuals.
GASTROINTESTINAL IMAGING: CT Colonography: Screening in an Older Population Kim et al for patients with E2 fi ndings. Findings that were likely not important but were incompletely characterized were coded as E3, and fi ndings that were potentially important were coded as E4. For the E3 and E4 categories, a specifi c recommendation regarding further imaging evaluation was made in the clinical report. A review of the electronic medical record was undertaken to determine whether additional imaging examinations were undertaken and to confi rm the fi nal extracolonic diagnosis.
Statistical Analysis
For positive CT colonography examinations, an established matching algorithm was used to determine concordance between CT colonography and OC for a given fi nding ( 11 ) . This algorithm allowed for a degree of uncertainty in localization and size at colonoscopy. A polyp had to be located in the same segment or the adjacent segment and be within 50% of the size reported with CT colonography to be considered a true match. Both neoplastic (eg, adenomas) and nonneoplastic (eg, hyperplastic, mucosal polyps) entities were considered true matches, whereas stool was not considered a match. The CT colonography-OC concordance rate was defi ned as the number of true structural matches between the two modalities divided by the total number of nondiminutive polyps reported at CT colonography.
Comparison between our older cohort and the general University of Wisconsin screening CT colonography population were made by using the Student t test for independent samples of continuous outcomes. The Pearson x 2 and Fisher exact tests were used for categorical outcomes. A P value of less than or equal to .05 was considered to indicate a signifi cant difference.
Results
The mean age in the older cohort (69.2 years 6 3.8 [standard deviation]; n = 577) was signifi cantly older than that in the entire screening population (56.9 years 6 7.3; n = 5176) ( P , .001). In addition, there was a signifi cant difference in the face) categories for polyps less than 3 cm in size. For masses 3 cm in size or larger, descriptive terms such as saddle, hemicircumferential, annular, and carpet were used. Location was originally reported by colonic segments (ie, cecum, ascending, transverse, descending, sigmoid, or rectum). For the purposes of our study, these segmental locations were condensed into proximal and distal categories relative to the splenic fl exure to mirror prior surgical and colonoscopic series. All examination fi ndings were classifi ed according to C-RADS conventions ( 9 ): C0 = nondiagnostic, C1 = negative fi ndings (no or only diminutive polyps), C2 = one or two 6-9-mm polyps, C3 = one polyp 10 mm or greater in size or multiple (at least three) 6-9-mm polyps, and C4 = a colonic mass at least 3 cm in size.
At pathologic analysis, adenomas were classifi ed as tubular, tubulovillous (25%-75% villous component), villous, or serrated. HGD was noted when present. Invasive carcinoma was defi ned as malignant extension past the muscularis mucosae. Advanced adenomas were defi ned as tubular adenomas at least 10 mm in size or adenomas of any size that had a substantial ( . 25%) villous component and/or HGD. Advanced neoplasia included both advanced adenomas and adenocarcinomas. The specimens were read by one of 11 pathologists with experience ranging from 5 to 30 years.
Extracolonic Findings
The reconstructed 5-mm image series was used for review of extracolonic fi ndings, which were prospectively categorized according to C-RADS conventions and recorded in the CT colonography database. For individuals with more than one extracolonic fi nding, the examination was classifi ed by the fi nding with the highest category score. In accordance with C-RADS, examinations limited by artifact were coded as E0. Examinations that demonstrated normal anatomy or an anatomic variant were coded as E1. Extracolonic fi ndings that were clinically not important or did not require any additional work-up were coded as E2. In the clinical report, no additional imaging was recommended Princeton, NJ). There was continuous infl ow of carbon dioxide throughout image acquisition. Scans were initiated after confi rmation of adequate distention, which was determined by a combination of image review and measurements of attained intracolonic equilibrium pressures. No spasmolytics were administered.
Image acquisition was undertaken with a 16-section multidetector CT scanner (LightSpeed; GE Healthcare, Waukesha, Wis). Technique consisted of 1.25-mm section collimation, 1-mm reconstruction interval, 120 kVp, and either a fi xed tube current-time product (50-75 mAs) or tube-current modulation (range, 30-300 mA) with the noise index set at 50 . An additional reconstruction of the supine data with 5-mm section collimation and a 3-mm interval was undertaken to facilitate extracolonic review. Soft tissue, lung, and bone window settings were used when appropriate for the extracolonic review. All data were networked to a picture archiving and communication system and a three-dimensional workstation (V3D Colon; Viatronix, Stony Brook, NY) for postprocessing. Interpretation was undertaken by one of fi ve radiologists (D.H.K., P.J.P, J.L.H, and two nonauthors). At the beginning of the study period, reader CT colonography experience ranged from 50 to over 200 pathologically proved CT colonography cases. At the conclusion of the study, all radiologists had experience with at least 700 CT colonography examinations.
Colonic Findings
For CT colonography-depicted polyps at least 6 mm in diameter, the characteristics of size, morphology, and location were prospectively determined and recorded in a customized CT colonography database (Access; Microsoft, Redmond, Wash). Size was determined by measuring the longest dimension by using both the two-and three-dimensional images. For pedunculated polyps, the longest dimension of the polyp head was measured, with the polyp stalk excluded. Polyp morphology was divided into sessile, pedunculated, and fl at (plaque-like, raised Յ 3 mm from the colonic sur-GASTROINTESTINAL IMAGING: CT Colonography: Screening in an Older Population Kim et al diagnoses. Vascular aneurysms ( n = 18) constituted 85.7% of this group. Other diagnoses included an unsuspected lung cancer ( n = 1), malrotation ( n = 1), and a femoral hernia ( n = 1). For the group of individuals for whom an additional study was recommended (E3 or E4) but none was undertaken, the mean duration of chart review to establish the lack E3 and E4 are the two categories that may lead to further imaging. In the older cohort, 15.4% (89 of 577) of patients fell into one of these categories. However, the actual work-up rate for incidental extracolonic fi ndings seen at CT colonography was 7.8% (45 of 577). Overall, 3.6% (21 of 577) of these fi ndings were substantial but unsuspected gender proportions between our cohort (man-to-woman ratio, 51.8%:48.2%) and the general population (man-to-women ratio, 45.4%:54.6%) ( P , .001). Table 1 shows selected program outcomes for our older cohort compared with those for the general CT colonography screening group inclusive of all ages. At a 6-mm threshold, the OC referral rate for the older age cohort was 15.3% (88 of 577). Overall, 277 polypectomies were performed in these referred patients, resulting in the removal of 103 nondiminutive adenomas and the biopsy of fi ve unsuspected cancers. For adenomas, excluding cancers, the per-patient test positivity rate was 10.9% (63 of 577) at the 6-mm threshold and 6.8% (39 of 577) at the 10-mm threshold. The per-patient false-positive rates were 3.6% (21 of 577) and 2.1% (12 of 577) at the 6-and 10-mm thresholds, respectively. Patients with falsepositive fi ndings were those who were sent for OC and had fi ndings of a nonadenomatous (hyperplastic or mucosal) polyp or had a polyp that was not seen. From the group of harvested lesions, 54 adenomas met advanced status criteria. When these were added to the cancers, there were 59 advanced neoplastic lesions with an overall prevalence of 7.6% (44 of 577) for the older age group. Not included in this analysis were the 30 patients enrolled in the institutional review board-approved surveillance protocol who had 37 small (6-9-mm) polyps. The CT colonography-OC concordance rate was 90.8% (158 of 174).
The characteristics of advanced neoplasia seen within the older cohort are summarized in Table 2 . Size was a defi ning characteristic for this group. The majority were determined by size criteria alone; 94.9% (56 of 59) of lesions were 10 mm or greater in size ( Fig 1 ) . Only three advanced adenomas were smaller than a centimeter in size; all of these had a villous component. No HGD or invasive carcinoma was seen in the subcentimeter group. All cancers ( n = 5) were large, with a mean size of 44 mm 6 13.4.
C-RADS classifi cations for colonic and extracolonic fi ndings are presented in Figure 2 . For extracolonic fi ndings, Note.-Unless otherwise specifi ed, data are numbers of patients, with percentages in parentheses.
* Data from a previous analysis (2). Note.-Unless otherwise specifi ed, data are numbers of lesions.
* Data from a previous analysis (2). † Data are mean 6 standard deviation. ‡ Does not include polyps from patients undergoing CT colonographic surveillance. § Histologic fi ndings sum to greater than the number of lesions in each category because HGD was used as a descriptive modifi er for tubular, tubulovillous, villous, and serrated polyps when applicable.
|| Includes fi ndings given as "not recorded" and terms for masses Ն 3 cm (eg, carpet, saddle, annular, invasive).
# Relative to the splenic fl exure.
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yields are a concrete program outcome. They are the group of target lesions removed that is felt to most likely decrease future cancer incidence. In our study, the advanced neoplasia prevalence was 7.6% (44 of 577) for the older age group, which is more than double that which we had previously reported (2) in the general screening population ( P , .001).
The result suggests that relative CT colonography performance does not drop off in an older cohort, as would be suggested if yield had decreased or performance within subgroups of the population, can be suggested through surrogate measures. The prevalence of advanced neoplasia is a useful measure for evaluating CT colonography performance in the clinical setting. Several studies ( 14-16 ) have used advanced neoplasia yield to assess relative performance. In addition, as opposed to sensitivity and specifi city measurements that give the expected performance when applied to a given clinical population, advanced adenoma of further imaging was 724 days 6 461 (range, 202-1863 days).
No substantial complications were seen in the older cohort. Specifi cally, no perforations or major hemorrhage occurred either at CT colonography screening or at therapeutic OC for referred patients with positive CT fi ndings.
Discussion
CT colonography has been shown to have performance equivalent to that of OC in both screening and higher risk cohorts in several large multicenter trials ( 1, (11) (12) (13) . In addition, it has been shown to enable more effi cient detection of advanced neoplasia compared with OC when coupled with selective polypectomy strategies ( 2 ) . Widespread implementation of CT colonography could potentially improve screening adherence by the general populace and may represent a more attractive screening option for older individuals owing to its less invasive nature. However, there are limited data specifi c to the older cohort. Questions have arisen whether the CT colonography performance seen in the large trials can be extrapolated to this older group, given the typically younger age of the participants in those trials ( 8 ) . In addition, there are limited data regarding CT colonography program outcomes (eg, OC referral or extracolonic work-up rate), which may differ in the older group. Our study was undertaken to address these concerns and present benchmark values for this older (65-79 years) cohort.
At fi rst glance, the determination of CT colonography performance within an observational study design may appear to be diffi cult to obtain. As opposed to a clinical trial, measurements such as sensitivity or specifi city cannot be obtained because not all CT colonography examinations undergo a confi rmatory test in the clinical setting. In other words, only patients with positive fi ndings at CT colonography undergo OC for removal of detected polyps, while patients with negative examinations are relegated to routine 5-year follow-up. Thus, neither the CT colonography true-nor falsenegative rate can be determined. However, CT colonography performance, particularly in regards to the relative ( 23 ), the cancer and HGD rates in diminutive ( Յ 5-mm) polyps were each 0.03% (one of 3744), and no cancers were seen in the small-polyp (6-9 mm) group in a large colonoscopic series from Indiana ( 24 ) . Given these observations and the average life expectancy of this cohort, a strong argument could be made to set a larger size threshold for referral to OC. A 10-mm threshold would further decrease the referral rate while capturing close to 95% (56 of 59) of the advanced neoplastic entities in our study. The small number of subcentimeter advanced adenomas could be identifi ed by demonstrating interval growth at surveillance imaging. In our older cohort, the E3 and E4 categories constituted 15.4% (89 of 577) of the examinations with incidental extracolonic fi ndings. These were the patients for whom additional imaging could be recommended. In our practice, extracolonic fi ndings placed in the E1 or E2 categories cannot have a recommendation for any further imaging in the formal report. Although the prevalence of E3 or E4 fi ndings was higher in the older cohort than in the general screening group ( P = .0012) and was slightly higher than the 7.4%-11.4% range of potentially important extracolonic fi ndings reported in other series (25) (26) (27) (28) , the actual work-up rate that occurred in this cohort was 7.8% (45 of 577). This mirrors what has been noted in the general population, where the actual work-up rate is less than the extracolonic fi nding rate ( 29 ). There are a number of causes that may account for this observation. In some patients, the fi nding may be a known diagnosis, and in others, the work-up may be deferred owing to the patient's specifi c clinical situation or comorbidities.
It is important to bear in mind the potential benefi ts regarding the extracolonic evaluation. In our study, 3.6% of examinations revealed an important but unsuspected extracolonic diagnosis; the vast majority of these were unsuspected vascular aneurysms ( n = 18).
However, this rate remains in a similar range as compared with other screening modalities. Lieberman et al ( 20 ) reported an OC referral rate from positive screening fl exible sigmoidoscopy of 16.4% in an older population of men from the Veterans Administration. It is important to remember that, even with this increased referral rate, nearly 85% (489 of 577) of individuals in this age range who are screened with CT colonography avoid the need for OC, thus decreasing the possibility of major OC complications that are known to be increased in this older cohort ( 21 ) .
The characteristics of advanced neoplasia seen in our older cohort were similar to those described in the general population ( 22 ) . Concerns have been raised that the characteristics of advanced neoplasia, such as a small size or fl at nature, may be different for this specifi c older age group, with potentially negative effects on CT colonography performance ( 8 ) . Overall, most (56 of 59, 94.9%) of the advanced neoplasias were large ( Ն 10-mm) lesions. A minority were subcentimeter lesions, typically meeting criteria with a villous component as opposed to the presence of HGD or cancer. Indeed, for this older cohort, there were no cases of subcentimeter polyps with foci of HGD or cancer. Other large colonoscopic-based remained the same in relation to the general population. The overall increase in prevalence is expected, given the cohort demographics of increased age and increased percentage of men (17) (18) (19) .
Other surrogate performance measures include the CT colonography-OC concordance rate (158 of 174, 90.8%) and the per-patient false-positive rate (21 of 577, 3.6%). As described previously, CT colonography-OC concordance rate is a per-polyp measure, while the falsepositive rate is defi ned on a per-patient basis. The high CT colonography-OC concordance rate and low false-positive rate in our observational study both suggest that overdiagnosis of nondisease does not occur to a large extent in the older cohort.
A key program outcome regarding CT colonography use in the older cohort involves the referral rate to OC after a positive CT colonography examination. A high referral rate in this group could negatively affect the overall utility of CT colonography as a screening measure. We would expect an increase in colonoscopy referral in this subgroup given the positive association of increased age with increased adenoma prevalence ( 18, 19 ) . We found a rate of 15.3% (88 of 577) for the 65-79-year-old cohort, which is a signifi cant increase over that in the general population ( P , .001). The early presymptomatic detection of such conditions would likely positively affect the individual. A recent modeling study ( 30 ) of CT colonographic screening in an older ( Ն 65 years) population showed both clinical effi cacy and cost effectiveness related to the added benefi ts of aortic aneurysm detection during extracolonic review. The overall safety profi le of CT colonography was excellent, with no perforations or major hemorrhages seen in this cohort. Unlike OC, for which complications may increase with increasing age ( 21 ), they remain an unlikely event at CT colonography, presumably related to its minimally invasive nature.
One limitation of our study is related to its observational design. As discussed above, this precludes the calculation of performance measurements such as sensitivity or specifi city. The surrogate measures that can be obtained only provide indirect evidence regarding CT colonography performance. However, these measures, such as advanced neoplastic yield, have the advantage of representing concrete outcomes with real future clinical effect where the screening target lesion has been removed. Another study limitation involves the single center nature of our series. The generalizability of our results could potentially be debated, but the study cohort was large and interpretations were undertaken by multiple readers.
In conclusion, CT colonography performance is maintained in an older age cohort, as evidenced by the surrogate measure of advanced neoplasia prevalence. In addition, program outcome measures, such as OC referral and extracolonic work-up rates, remain in a similar range to other screened groups. In this cohort, CT colonography remains a safe modality. Overall, the observations from this clinical experience confi rm that CT colonography may be a valuable screening modality in the older population.
